Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.

Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, Nicholson JC, Murray MJ, Bilmire DF, Stoneham S, Arul GS, Olson TA, Stark D, Shaikh F, Amatruda JF, Covens A, Gershenson DM, Frazier AL.

Cancer. 2016 Jan 15;122(2):230-7. doi: 10.1002/cncr.29732. Epub 2015 Oct 20. Erratum in: Cancer. 2018 Mar 15;124(6):1302.

2.

Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.

Cushing B, Giller R, Ablin A, Cohen L, Cullen J, Hawkins E, Heifetz SA, Krailo M, Lauer SJ, Marina N, Rao PV, Rescorla F, Vinocur CD, Weetman RM, Castleberry RP.

Am J Obstet Gynecol. 1999 Aug;181(2):353-8.

PMID:
10454682
3.

Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.

Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, Weetman R, Cullen J, Rogers P, Vinocur C, Stolar C, Rescorla F, Hawkins E, Heifetz S, Rao PV, Krailo M, Castleberry RP.

J Clin Oncol. 1999 Jul;17(7):2137-43.

PMID:
10561269
4.

Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.

Reddihalli PV, Subbian A, Umadevi K, Rathod PS, Krishnappa S, Nanaiah SP, Bafna UD.

Eur J Obstet Gynecol Reprod Biol. 2015 Sep;192:17-21. doi: 10.1016/j.ejogrb.2015.06.017. Epub 2015 Jun 25.

PMID:
26142911
5.

Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).

Mangili G, Scarfone G, Gadducci A, Sigismondi C, Ferrandina G, Scibilia G, Viganò R, Tateo S, Villa A, Lorusso D.

Gynecol Oncol. 2010 Oct;119(1):48-52. doi: 10.1016/j.ygyno.2010.05.035.

PMID:
20599258
6.

Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.

Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A.

Int J Surg. 2008 Oct;6(5):382-6. doi: 10.1016/j.ijsu.2008.07.002. Epub 2008 Jul 16.

7.

The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.

Göbel U, Calaminus G, Schneider DT, Koch S, Teske C, Harms D.

Klin Padiatr. 2006 Nov-Dec;218(6):309-14.

PMID:
17080332
8.

[BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].

Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U, et al.

Klin Padiatr. 1993 Jul-Aug;205(4):231-40. German.

PMID:
7690864
9.

Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.

Lee CW, Song MJ, Park ST, Ki EY, Lee SJ, Lee KH, Ryu KS, Park JS, Hur SY.

World J Surg Oncol. 2011 Oct 11;9:123. doi: 10.1186/1477-7819-9-123.

10.

The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.

Mangili G, Sigismondi C, Lorusso D, Cormio G, Candiani M, Scarfone G, Mascilini F, Gadducci A, Mosconi AM, Scollo P, Cassani C, Pignata S, Ferrandina G.

Ann Oncol. 2017 Feb 1;28(2):333-338. doi: 10.1093/annonc/mdw563.

PMID:
27803008
11.

Mature and immature teratoma: A report from the second Italian pediatric study.

Terenziani M, D'Angelo P, Inserra A, Boldrini R, Bisogno G, Babbo GL, Conte M, Dall' Igna P, De Pasquale MD, Indolfi P, Piva L, Riccipetitoni G, Siracusa F, Spreafico F, Tamaro P, Cecchetto G.

Pediatr Blood Cancer. 2015 Jul;62(7):1202-8. doi: 10.1002/pbc.25423. Epub 2015 Jan 28.

PMID:
25631333
12.

Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.

Alwazzan AB, Popowich S, Dean E, Robinson C, Lotocki R, Altman AD.

Int J Gynecol Cancer. 2015 Nov;25(9):1616-22. doi: 10.1097/IGC.0000000000000541.

13.

Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.

Biskup W, Calaminus G, Schneider DT, Leuschner I, Göbel U.

Klin Padiatr. 2006 Nov-Dec;218(6):303-8.

PMID:
17080331
14.

Ovarian immature teratoma: treatment and outcome in a single institutional cohort.

Vicus D, Beiner ME, Clarke B, Klachook S, Le LW, Laframboise S, Mackay H.

Gynecol Oncol. 2011 Oct;123(1):50-3. doi: 10.1016/j.ygyno.2011.06.037. Epub 2011 Jul 20.

PMID:
21764111
15.

Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.

Hoskins PJ, Le N, Gilks B, Tinker A, Santos J, Wong F, Swenerton KD.

J Clin Oncol. 2012 May 10;30(14):1656-62. doi: 10.1200/JCO.2011.40.1646. Epub 2012 Apr 9.

PMID:
22493415
16.

[Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].

Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.

Ai Zheng. 2006 Dec;25(12):1529-32. Chinese.

PMID:
17166380
17.

Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period.

Akeson M, Zetterqvist BM, Dahllöf K, Jakobsen AM, Brännström M, Horvath G.

Int J Gynecol Cancer. 2008 May-Jun;18(3):453-9. doi: 10.1111/j.1525-1438.2007.01051.x.

PMID:
18476948
18.

Management of malignant ovarian immature teratoma. Role of adriamycin.

Vergote IB, Abeler VM, Kjørstad KE, Tropé C.

Cancer. 1990 Sep 1;66(5):882-6. Review.

PMID:
2201432
19.

Immature teratoma of the ovary.

Ayhan A, Aksu T, Selçuk Tuncer Z, Mercan R, Ozbay G.

Eur J Gynaecol Oncol. 1993;14(3):205-7.

PMID:
8508876
20.

Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.

Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B; Pediatric Oncology Group 9048; Children's Cancer Group 8891.

J Clin Oncol. 2004 Sep 1;22(17):3563-9.

PMID:
15337806

Supplemental Content

Support Center